Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update

Virax Biolabs Group Limited (NASDAQ:VRAX) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 350,900 shares, an increase of 757.9% from the August 15th total of 40,900 shares. Based on an average daily trading volume, of 502,100 shares, the days-to-cover ratio is currently 0.7 days. Currently, 9.0% of the company’s stock are short sold. Currently, 9.0% of the company’s stock are short sold. Based on an average daily trading volume, of 502,100 shares, the days-to-cover ratio is currently 0.7 days.

Virax Biolabs Group Stock Up 0.2%

VRAX stock opened at $0.58 on Friday. The stock’s 50 day simple moving average is $0.79 and its 200 day simple moving average is $0.98. Virax Biolabs Group has a fifty-two week low of $0.52 and a fifty-two week high of $3.62.

Virax Biolabs Group Company Profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.